FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1713072086> ?p ?o ?g. }

• W1713072086 endingPage "3499" @default.
• W1713072086 startingPage "3499" @default.
• W1713072086 abstract "The normal metabolite methylglyoxal (MG) specifically kills cancer cells by inhibiting glycolysis and mitochondrial respiration without much adverse effect upon normal cells. Though the anticancer property of MG is well documented, its gradual enzymatic degradation in vivo has prompted interest in developing a nanoparticulate drug delivery system to protect it and also to enhance its efficacy.MG-conjugated chitosan nanoparticles (Nano-MG) were prepared by conjugating the carbonyl group of MG with the amino group of chitosan polymer (Schiff's base formation). Nano-MG were characterized in detail using the dynamic light scattering method, zeta potential measurement, Fourier transform infrared spectroscopy, and transmission electron microscopic analysis. Amount of MG anchored to Nano-MG, stability of Nano-MG, and in vitro release of MG from Nano-MG were estimated spectrophotometrically. Ehrlich ascites carcinoma (EAC) cells, human breast cancer cell line HBL-100, and lung epithelial adenocarcinoma cell line A549 were used as test systems to compare Nano-MG with bare MG in vitro. Cytotoxicity to EAC cells was evaluated by the trypan blue dye exclusion test, and cell viability of HBL-100 and A549 cells were studied using 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide (MTT) assay. Apoptosis of HBL-100 cells was assessed by flow cytometry and confocal microscopy. In vivo studies were performed on both EAC cells inoculated and also in sarcoma-180-induced solid tumor-bearing Swiss albino mice to assess the anticancer activity of Nano-MG in comparison to bare MG with varying doses, times, and administrative routes.Fourier transform infrared spectroscopy revealed the presence of imine groups in Nano-MG due to conjugation of the amino group of chitosan and carbonyl group of MG with diameters of nanoparticles ranging from 50-100 nm. The zeta potential of Nano-MG was +21 mV and they contained approximately 100 μg of MG in 1 mL of solution. In vitro studies with Nano-MG showed higher cytotoxicity and enhanced rate of apoptosis in the HBL-100 cell line in comparison with bare MG, but no detrimental effect on normal mouse myoblast cell line C2C12 at the concerned doses. Studies with EAC cells also showed increased cell death of nearly 1.5 times. Nano-MG had similar cytotoxic effects on A549 cells. In vivo studies further demonstrated the efficacy of Nano-MG over bare MG and found them to be about 400 times more potent in EAC-bearing mice and nearly 80 times more effective in sarcoma-180-bearing mice. Administration of ascorbic acid and creatine during in vivo treatments augmented the anticancer effect of Nano-MG.The results clearly indicate that Nano-MG may constitute a promising tool in anticancer therapeutics in the near future." @default.
• W1713072086 created "2016-06-24" @default.
• W1713072086 creator A5026481569 @default.
• W1713072086 creator A5034752348 @default.
• W1713072086 creator A5044141575 @default.
• W1713072086 creator A5045855363 @default.
• W1713072086 creator A5061650031 @default.
• W1713072086 creator A5062398432 @default.
• W1713072086 creator A5072334144 @default.
• W1713072086 date "2015-05-01" @default.
• W1713072086 modified "2023-09-27" @default.
• W1713072086 title "Nanofabrication of methylglyoxal with chitosan biopolymer: a potential tool for enhancement of its anticancer effect" @default.
• W1713072086 cites W118324404 @default.
• W1713072086 cites W144422475 @default.
• W1713072086 cites W1484037209 @default.
• W1713072086 cites W1516287112 @default.
• W1713072086 cites W1528840891 @default.
• W1713072086 cites W1608101507 @default.
• W1713072086 cites W1631973292 @default.
• W1713072086 cites W1770726668 @default.
• W1713072086 cites W1776564239 @default.
• W1713072086 cites W1968257470 @default.
• W1713072086 cites W1976256792 @default.
• W1713072086 cites W1992595116 @default.
• W1713072086 cites W2000947349 @default.
• W1713072086 cites W2011090397 @default.
• W1713072086 cites W2025967280 @default.
• W1713072086 cites W2038419425 @default.
• W1713072086 cites W2042546801 @default.
• W1713072086 cites W2057572946 @default.
• W1713072086 cites W2061238696 @default.
• W1713072086 cites W2061895500 @default.
• W1713072086 cites W2062063474 @default.
• W1713072086 cites W2066354221 @default.
• W1713072086 cites W2079745748 @default.
• W1713072086 cites W2086930990 @default.
• W1713072086 cites W2091103817 @default.
• W1713072086 cites W2094690600 @default.
• W1713072086 cites W2097792751 @default.
• W1713072086 cites W2102453083 @default.
• W1713072086 cites W2114918609 @default.
• W1713072086 cites W2125364971 @default.
• W1713072086 cites W2139169365 @default.
• W1713072086 cites W28486177 @default.
• W1713072086 cites W4239951311 @default.
• W1713072086 cites W2408913538 @default.
• W1713072086 doi "https://doi.org/10.2147/ijn.s78284" @default.
• W1713072086 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4435252" @default.
• W1713072086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25999714" @default.
• W1713072086 hasPublicationYear "2015" @default.
• W1713072086 type Work @default.
• W1713072086 sameAs 1713072086 @default.
• W1713072086 citedByCount "4" @default.
• W1713072086 countsByYear W17130720862016 @default.
• W1713072086 countsByYear W17130720862020 @default.
• W1713072086 countsByYear W17130720862021 @default.
• W1713072086 countsByYear W17130720862022 @default.
• W1713072086 crossrefType "journal-article" @default.
• W1713072086 hasAuthorship W1713072086A5026481569 @default.
• W1713072086 hasAuthorship W1713072086A5034752348 @default.
• W1713072086 hasAuthorship W1713072086A5044141575 @default.
• W1713072086 hasAuthorship W1713072086A5045855363 @default.
• W1713072086 hasAuthorship W1713072086A5061650031 @default.
• W1713072086 hasAuthorship W1713072086A5062398432 @default.
• W1713072086 hasAuthorship W1713072086A5072334144 @default.
• W1713072086 hasBestOaLocation W17130720861 @default.
• W1713072086 hasConcept C121608353 @default.
• W1713072086 hasConcept C126322002 @default.
• W1713072086 hasConcept C150903083 @default.
• W1713072086 hasConcept C171250308 @default.
• W1713072086 hasConcept C178790620 @default.
• W1713072086 hasConcept C181199279 @default.
• W1713072086 hasConcept C185592680 @default.
• W1713072086 hasConcept C192562407 @default.
• W1713072086 hasConcept C207001950 @default.
• W1713072086 hasConcept C2777477808 @default.
• W1713072086 hasConcept C2778592357 @default.
• W1713072086 hasConcept C2778636629 @default.
• W1713072086 hasConcept C2779732960 @default.
• W1713072086 hasConcept C2779820397 @default.
• W1713072086 hasConcept C521977710 @default.
• W1713072086 hasConcept C55493867 @default.
• W1713072086 hasConcept C71924100 @default.
• W1713072086 hasConcept C86803240 @default.
• W1713072086 hasConcept C98274493 @default.
• W1713072086 hasConceptScore W1713072086C121608353 @default.
• W1713072086 hasConceptScore W1713072086C126322002 @default.
• W1713072086 hasConceptScore W1713072086C150903083 @default.
• W1713072086 hasConceptScore W1713072086C171250308 @default.
• W1713072086 hasConceptScore W1713072086C178790620 @default.
• W1713072086 hasConceptScore W1713072086C181199279 @default.
• W1713072086 hasConceptScore W1713072086C185592680 @default.
• W1713072086 hasConceptScore W1713072086C192562407 @default.
• W1713072086 hasConceptScore W1713072086C207001950 @default.
• W1713072086 hasConceptScore W1713072086C2777477808 @default.
• W1713072086 hasConceptScore W1713072086C2778592357 @default.
• W1713072086 hasConceptScore W1713072086C2778636629 @default.
• W1713072086 hasConceptScore W1713072086C2779732960 @default.

• next